BlueRock Therapeutics Announces New Board Chair, New President and CEO

CAMBRIDGE, Mass., July 26, 2021 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today that Emile Nuwaysir, Ph.D., current President and CEO, ... Biopharmaceuticals, Neurology, Personnel BlueRock Therapeutics, Bayer AG, Parkinson's disease, engineered cell therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news